epigenomics
Sitemap Search Glossary Terms Contact Deutsch
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Epigenomics AG Reports Conclusions from PRESEPT Study Audit Thursday, 04.02.2010
  • Differences in analytical instrument read-out requires verification and potential retesting of samples measured in laboratory with deviating results 
  • Top-line data expected still in Q1 2010 
  • No impact on commercial strategy expected

Press release, Berlin, Germany, and Seattle, WA, U.S.A.

Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Epigenomics AG Releases Preliminary PRESEPT Study Data Friday, 15.01.2010
Ad Hoc Announcement pursuant of §15 WpHG (German Securities Trading Act): Epigenomics AG: Licensing Partner Quest Diagnostics Introduces Colorectal Cancer Blood Test in the U.S. Monday, 11.01.2010

top of the page